Publications by authors named "Thomas Grader-Beck"

Claim this Profile
S
Safety and Efficacy of Ianalumab in Patients With Sjögren's Disease: 52-Week Results From a Randomized, Placebo-Controlled, Phase 2b Dose-Ranging Study.
Thomas Dörner, Simon J Bowman, Robert Fox, Xavier Mariette, Athena Papas, Thomas Grader-Beck

Arthritis Rheumatol· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Characteristics associated with patient-reported treatment success in psoriatic arthritis.
Christeen Samuel, Amanda Finney, Thomas Grader-Beck, Uzma Haque, John Miller

Rheumatology (Oxford)· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Centering Weight Management Clinical Decision Support in Primary Care on Patients With Obesity and Practitioners: A Proof-Of-Concept Study.
Kimberly A Gudzune, Jessica L Schwartz, Kelly Olsson, Erik Almazan, Thomas Grader Beck

Obes Sci Pract· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and efficacy of subcutaneous iscalimab (CFZ533) in two distinct populations of patients with Sjögren's disease (TWINSS): week 24 results of a randomised, double-blind, placebo-controlled, phase 2b dose-ranging study.
Benjamin A Fisher, Xavier Mariette, Athena Papas, Thomas Grader-Beck, Hendrika Bootsma

Lancet· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dissemination and Early Experiences of an Electronic Patient-Reported Outcome Measure in Nephrology Clinic.
Dipal M Patel, Sumeska Thavarajah, Jack Bitzel, Thomas Grader-Beck, Derek M Fine

Clin J Am Soc Nephrol· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Antibodies to Both Ro52 and Ro60 for Identifying Sjögren's Syndrome Patients Best Suited for Clinical Trials of Disease-Modifying Therapies.
Berkan Armağan, Susan A Robinson, Adriana Bazoberry, Jamie Perin, Thomas Grader-Beck

Arthritis Care Res (Hoboken)· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Designing an electronic medical record alert to identify hospitalised patients with HIV: successes and challenges.
Walid El-Nahal, Thomas Grader-Beck, Kelly Gebo, Elizabeth Holmes, Kayla Herne

BMJ Health Care Inform· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
PROMIS Provides a Broader Overview of Health-related Quality of Life Than the ESSPRI in Evaluation of Sjögren Syndrome.
Dana D DiRenzo, Susan Robinson, Clifton O Bingham, Alan N Baer, Thomas Grader-Beck

J Rheumatol· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Measurement of Minimal Disease Activity in Psoriatic Arthritis Using the Patient-Reported Outcomes Measurement Information System-Physical Function or the Health Assessment Questionnaire Disability Index.
Erin Chew, Jamie Perin, Thomas Grader-Beck, Ana-Maria Orbai

Arthritis Care Res (Hoboken)· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and efficacy of subcutaneous ianalumab (VAY736) in patients with primary Sjögren's syndrome: a randomised, double-blind, placebo-controlled, phase 2b dose-finding trial.
Simon J Bowman, Robert Fox, Thomas Dörner, Xavier Mariette, Athena Papas, Thomas Grader-Beck

Lancet· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Ultrasound-Guided Biopsy of Suspected Salivary Gland Lymphoma in Sjögren's Syndrome.
Alan N Baer, Thomas Grader-Beck, Brendan Antiochos, Julius Birnbaum, Joel M Fradin

Arthritis Care Res (Hoboken)· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical Characteristics of Hydralazine-induced Lupus.
Homa Timlin, Michael Wu, Monica Crespo-Bosque, Duvuru Geetha, Ashley Ingolia, Thomas Grader-Beck

Cureus· June 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A validated method of labial minor salivary gland biopsy for the diagnosis of Sjögren's syndrome.
Jean Kim, Daniel Sun, Rebecca Ozl, Thomas Grader-Beck, Julius Birnbaum

Laryngoscope· September 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Ocular complications of primary Sjögren syndrome in men.
Priya M Mathews, Sarah Hahn, Michelle Hessen, Jean Kim, Thomas Grader-Beck

Am J Ophthalmol· September 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Ocular and systemic morbidity in a longitudinal cohort of Sjögren's syndrome.
Esen Karamursel Akpek, Priya Mathews, Sarah Hahn, Michelle Hessen, Jean Kim, Thomas Grader-Beck

Ophthalmology· January 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Antibodies recognising sulfated carbohydrates are prevalent in systemic sclerosis and associated with pulmonary vascular disease.
Thomas Grader-Beck, Francesco Boin, Stephan von Gunten, David Smith, Antony Rosen

Ann Rheum Dis· December 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dermatomyositis as the initial presentation of a large anaplastic T-cell lymphoma.
Jin Kyun Park, Andrea P Subhawong, Carol M Ziminski, Thomas Grader-Beck

J Clin Oncol· May 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Elevation of intracellular cyclic AMP in alloreactive CD4(+) T Cells induces alloantigen-specific tolerance that can prevent GVHD lethality in vivo.
Matthew J O'Shaughnessy, Zong-Ming Chen, Irene Gramaglia, Patricia A Taylor, Angela Panoskaltsis-Mortari, Thomas Grader-Beck

Biol Blood Marrow Transplant· May 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Apoptotic splenocytes drive the autoimmune response to poly(ADP-ribose) polymerase 1 in a murine model of lupus.
Thomas Grader-Beck, Livia Casciola-Rosen, Thomas J Lang, Roman Puliaev, Antony Rosen

J Immunol· January 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Raynaud's phenomenon in mixed connective tissue disease.
Thomas Grader-Beck, Fredrick M Wigley

Rheum Dis Clin North Am· August 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
cAMP inhibits both Ras and Rap1 activation in primary human T lymphocytes, but only Ras inhibition correlates with blockade of cell cycle progression.
Thomas Grader-Beck, Andre A F L van Puijenbroek, Lee M Nadler, Vassiliki A Boussiotis

Blood· February 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Induction of immunologic tolerance for allogeneic hematopoietic cell transplantation.
Leonard J Appleman, Dimitrios Tzachanis, Thomas Grader-Beck, Andre A F L Van Puijenbroek, Vassiliki A Boussiotis

Leuk Lymphoma· June 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis